By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aeolus Pharmaceuticals Inc. 

23811 Inverness Place

Laguna Niguel  California  92677  U.S.A.
Phone: 949-481-9825 Fax: 949-481-9829


SEARCH JOBS


Industry
Biotechnology






Company News
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces First Quarter Fiscal Year 2016 Financial Results 2/17/2016 12:07:51 PM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Complete Results From Successful Study Showing AEOL 10150 Doubles Survival Rate Following Lung Damage Caused By Acute Radiation Exposure 5/4/2015 8:41:59 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Receives Orphan Drug Designation From US FDA For AEOL 10150 For Treatment Of Idiopathic Pulmonary Fibrosis 3/17/2015 11:30:34 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Files Investigational New Drug Application With U.S FDA To Enable Initiation Of Human Safety Studies For The Development Of AEOL 10150 As A Medical Countermeasure Against Lung Damage From Radiation Exposure 8/20/2014 11:20:07 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Third Quarter Fiscal Year 2014 Financial Results And Achievements In Lung-ARS Development Program 8/18/2014 9:38:16 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Additional Data Demonstrating Efficacy Of AEOL 10150 As A Medical Countermeasure Against Exposure To Nerve Agents, Sulfur Mustard Gas And Nitrogen Mustard Gas 7/1/2014 9:14:17 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Publication Of Data Demonstrating Efficacy Of AEOL 10150 In Animal CEES Model Of Mustard Gas Skin Exposure 6/18/2014 11:26:48 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) To Present At LD Micro Invitational Conference 6/3/2014 9:07:48 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Second Quarter Fiscal Year 2014 Financial Results And Achievements In Lung-ARS Development Program 5/16/2014 9:55:38 AM
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces First Quarter Fiscal Year 2014 Financial Results 2/17/2014 10:36:39 AM
12345678910...
//-->